FINO
FINAL DECISION TRANSACTION PROCESSED BY IB
05/07/2025
Voltar para busca
Dado oficial do USPTO
RONOMA
Sabia que essa marca já está registrada no Estados Unidos?
Antes de investir em nome, identidade e divulgação, valide risco de colisão e estratégia de registro para não perder tempo nem budget.
Active USPTO registrationTipo: VerbalEscritório: US
Snapshot rápido
RONOMA
ST13
US500000079373992Classe
5, 35, 42, 44
Pedido
79373992
Registro
7602065
Diagnóstico de risco e oportunidade
Leitura executiva para decisão de naming, protocolo e monitoramento.
Situação USPTO
Active USPTO registration
Tipo de processo
Pedido e registro
Eventos registrados
25
Atualização mais recente
03/04/2026
Classificação
Registrada
Tipo de marca
Verbal
Classes Nice
5, 35, 42, 44
Data de depósito
26/05/2023
Data de registro
17/12/2024
Data de expiração
-
Ação recomendada
Execute uma análise de colidência completa e valide classes antes de qualquer protocolo ou investimento de marca.
Próximo passo
Esses são os detalhes do processo de registro. Mesmo assim, o monitoramento constante é o que garante tranquilidade de que o seu principal ativo continue protegido.
Dados completos do processo
Campos estruturados da autoridade responsável e do histórico oficial.
Data da situação
17/12/2024
Última transação
03/04/2026
Escritório responsável
United States Patent and Trademark Office
Código da situação
700
Cadastro oficial
Principal Register
Código do desenho
4
Tipo de titular
99
Localização do titular
FR
Examinador
KUHN, RIO NICE
Unidade examinadora
N90
Localização atual
FILE REPOSITORY (FRANCONIA)
Titulares e representantes
Titulares
C. U. (pessoa física)
Representantes
Robert J. Kenney Willcox & Savage, P.C.
Classificação técnica
Classes Nice
Classe 5Classe 35Classe 42Classe 44
Códigos Vienna
Sem códigos Vienna disponíveis.
Produtos e serviços
Classe 5
Pharmaceutical products for treating diseases of the central nervous system and neurodegenerative diseases and particularly Alzheimer's; pharmaceuticals sold on prescriptionnamely those treating diseases of the central nervous system and neurodegenerative diseases and particularly Alzheimer's; chemical preparations for pharmaceutical or medical usenamely for diseases of the central nervous system and neurodegenerative diseases and particularly Alzheimer's; pharmaceutical preparations against neurodegenerative diseases and diseases of the central nervous system; pharmaceutical preparations for combating the symptoms of Alzheimer's disease; Pharmaceutical preparations for the treatment of Alzheimer's disease; Pharmaceutical preparations for all means of administrationnamely pharmaceutical preparations for the treatment of diseases of the central nervous system and neurodegenerative diseases and particularly Alzheimer's; pharmaceutical solutionsgels and powders for all types of administration for the treatment of diseases of the central nervous system and neurodegenerative diseases and particularly Alzheimer's; pharmaceutical preparations for treating diseases of the central nervous system and neurodegenerative diseases and particularly Alzheimer's by intranasal administration; pharmaceutical solutionsgels and powders for treating diseases of the central nervous system and neurodegenerative diseases and particularly Alzheimer's by intranasal administration
Classe 35
Public relations; database management; establishing statistics in the nature of compilation of statistics for business or commercial purposes; sales promotions; organization of exhibitions for commercial and advertising purposes; organizingmanagingconducting exhibitionsfairs for advertising or commercial purposes; collection and systematization of data for business purposes in a central file in the field of pharmaceuticalhealth and medical research and development; retail store services or wholesale store services featuring pharmaceuticals productspharmaceutical preparations against neurodegenerative diseases and diseases of the central nervous systempharmaceutical preparations for combating symptoms of Alzheimer's diseasepharmaceutical preparations for treating Alzheimer's diseasepharmaceutical solutionsgels and powders for all types of administration
Classe 42
Medical research; biological research; scientific research for medical purposes in the field of diseases of the central nervous system and neurodegenerative diseases and particularly Alzheimer's; information with respect to medical and scientific research relating to diseases of the central nervous system and neurodegenerative diseases and particularly Alzheimer's; providing laboratory research services in the field of diseases of the central nervous system and neurodegenerative diseases and particularly Alzheimer's; scientific research and development for medical purposes; scientific research in the field of chemistry; scientific research in the field of pharmacology; research and development of medicines; scientific research in the field of galenics; preclinical studies and research; clinical studies and research; consultancy with respect to pharmacology
Classe 44
Medical services; medical services relating to diseases of the central nervous system and neurodegenerative diseases and particularly Alzheimer's; treating symptoms relating to central nervous system diseases and neurodegenerative diseaseshealth care services for treating symptoms relating to central nervous diseases and neurodegenerative diseases; treating diseases of the central nervous system and neurodegenerative diseaseshealth care services for treating diseases of the central nervous system and neurodegenerative diseases; treating Alzheimer's disease and its symptomshealth care services for treating Alzheimer's disease and its symptoms; medical information services; providing medical information; providing information in the field of diagnosing and treating diseases of the central nervous system and neurodegenerative diseases and particularly Alzheimer'svia a website
Publicações
Histórico de despachos e eventos da marca no USPTO.
25 publicações encontradas
XXSS
GENERIC MADRID TRANSACTION SENT TO IB
23/05/2025
XXCR
GENERIC MADRID TRANSACTION CREATED
23/05/2025
FICR
FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
17/03/2025
OPNX
NOTIFICATION OF POSSIBLE OPPOSITION - PROCESSED BY IB
04/01/2025
NRCC
NOTICE OF REGISTRATION CONFIRMATION EMAILED
17/12/2024
R.PR
REGISTERED-PRINCIPAL REGISTER
17/12/2024
OPNS
NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
15/12/2024
OPNR
NOTIFICATION OF POSSIBLE OPPOSITION CREATED, TO BE SENT TO IB
12/12/2024
NPUB
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
15/10/2024
PUBO
PUBLISHED FOR OPPOSITION
15/10/2024
NONP
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
25/09/2024
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
07/09/2024
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
05/09/2024
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
05/09/2024
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
05/09/2024
RFNT
REFUSAL PROCESSED BY IB
08/04/2024
RFCS
NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
15/03/2024
RFRR
REFUSAL PROCESSED BY MPU
14/03/2024
RFCR
NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
23/02/2024
CNRT
NON-FINAL ACTION WRITTEN
22/02/2024
DOCK
ASSIGNED TO EXAMINER
20/02/2024
MAFR
APPLICATION FILING RECEIPT MAILED
18/07/2023
NWOS
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
14/07/2023
REPR
SN ASSIGNED FOR SECT 66A APPL FROM IB
13/07/2023
Proteção contínua da sua marca
Seja avisado a cada novo depósito que ameace RONOMA ou a sua marca.
Vigilância profissional por 24 meses: monitoramos o USPTO por você e alertamos a tempo de você se opor — antes que o conflito vire prejuízo.